James C. Czirr - Jan 12, 2022 Form 5 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director, 10%+ Owner
Signature
/s/ James C. Czirr
Stock symbol
GALT
Transactions as of
Jan 12, 2022
Transactions value $
$12,000
Form type
5
Date filed
12/1/2023, 04:50 PM
Next filing
Jan 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Gift -4.5K -0.59% 761K Jan 12, 2022 Direct F1
transaction GALT Common Stock Gift -4.5K -0.59% 761K Jan 12, 2022 Direct F1
transaction GALT Common Stock Gift -4.5K -0.59% 761K Jan 12, 2022 Direct F1
transaction GALT Common Stock Other $6K +1K +0.13% $6.00 761K Mar 31, 2022 Direct F2, F3
transaction GALT Common Stock Other $6K +1K +0.13% $6.00 761K Sep 30, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares transferred to child as a gift. Transaction does not constitute a sale pursuant to Rule 16a-5.
F2 Common stock received in satisfaction of $6,000 of dividends due on Series A Convertible Preferred Stock owned by James C. Czirr pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividends were payable on 3/31/2020 and 9/30/2020. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend.
F3 Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9.